• Bruce, L.J., Ghosh, S., King, M.J., Layton, D.M., Mawby, W.J., Stewart, G.W., Oldenborg, P.-A., Delaunay, J. & Tanner, J.A. (2002) Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex. Blood, 100, 18781885.
  • Colin, Y. (2002) Rh proteins: a family of structural membrane proteins with putative transport activity. Vox Sanguinis, 83, 179183.
  • Garratty, G. & Arndt, P. (1998) Determining the clinical significance of blood group alloantibodies: a reevaluation of the interpretation of monocyte monolayer assay results (abstract). Blood, 92, 563a.
  • Mollison, P.L., Engelfreit, C.P. & Contreras, M. (1993) Blood Transfusion in Clinical Medicine, 9th edn, p. 514. Blackwell, Oxford.
  • Mouro-Chanteloup, I., Delaunay, J., Gane, P., Nicholas, V., Johansen, M., Brown, E.J., Peters, L.L., Van Kim, C.L., Cartron J.P. & Colin, Y. (2003) Evidence that the red cell skeleton protein 4.2 interacts with the Rh membrane complex member CD47. Blood, 101, 338344.
  • Nance, S.J., Arndt, P. & Garratty, G. (1987) Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion, 27, 449452.
  • Oldenborg, P.-A., Zheleznyak, A., Fang, Y.-F., Lagenaur, C.F., Gresham, H.D. & Lindberg, F.P. (2000) Role of CD47 as a marker of self on red blood cells. Science, 288, 20512054.